The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for GI Stevenson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
36
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles).EBI
Merck Sharp and Dohme Research Laboratories
22
Oxazolidinones as novel human CCR8 antagonists.EBI
Glaxosmithkline
16
The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists.EBI
Glaxosmithkline
60
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.EBI
Merck Sharp & Dohme Research Laboratories
20
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor.EBI
Merck Sharp & Dohme Research Laboratories
2
Solid-phase synthesis of 2,3-disubstituted indoles: discovery of a novel, high-affinity, selective h5-HT2A antagonist.EBI
Merck Sharp & Dohme Research Laboratories
12
Serine derived NK1 antagonists. 2: A pharmacophore model for arylsulfonamide binding.EBI
Merck Sharp and Dohme Research Laboratories
41
Serine derived NK1 antagonists. 1: The effect of modifications to the serine substituents.EBI
Merck Sharp and Dohme Research Laboratories
37
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activity.EBI
Merck Sharp and Dohme Research Laboratories
5
4,4-Disubstituted piperidines: a new class of NK1 antagonist.EBI
Merck Sharp and Dohme Research Laboratories
10
Enhancing CD8+ T cells for adoptive T cell therapy by inhibiting PTPN1 (PTP1B) and PTPN2 (TC-PTP)BDB
Mcgill University
5
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.BDB
University of Georgia